GlassScriptPhysician profile
Samuel S Tapper
NPI 1255339685
$1,340,457.30
in general payments reported to CMS, 2019-2025
30 companies · $996 in 2025
The $996 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $209 · 2021: $1.3M · 2022: $7,769 · 2023: $1,088 · 2024: $671 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,754.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $1,334,960.35 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $1,891.16 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Medical LLC | $658.22 | 2019-2025 | Zenith Spiral-Z, Zenith, Zilver Ptx |
| Inari Medical, INC. | $587.39 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $404.18 | 2020-2023 | Xarelto |
| Endologix LLC | $379.73 | 2023-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Philips North America LLC | $295.48 | 2019-2021 | |
| Bolton Medical INC | $244.85 | 2019-2022 | |
| Shockwave Medical, INC | $141.70 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biocompatibles, INC. | $130.56 | 2019 | |
| Penumbra, INC. | $120.46 | 2025 | Penumbra System |
| Medtronic, INC. | $112.95 | 2021-2025 | Endurant Iis, Abre |
| Angiodynamics, INC. | $82.61 | 2020-2022 | |
| Cvrx, INC. | $61.19 | 2024 | Barostim Neo System |
| Becton, Dickinson and Company | $58.42 | 2024 | Venclose Maven Catheter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $50.66 | 2023-2025 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Lemaitre Vascular, INC. | $36.91 | 2025 | Artegraft Vascular Graft |
| Tactile Systems Technology INC | $33.86 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Silk Road Medical, INC. | $25.72 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiva Medical, INC. | $25.16 | 2023 | Cardiva Vascade 6/7f Vcs |
| Organogenesis INC. | $22.26 | 2024 | |
| Abbott Laboratories | $20.91 | 2023 | Diamondback Peripheral |
| Inspiremd LTD | $18.40 | 2025 | Cguard Prime Carotid Stent System |
| Terumo Medical Corporation | $17.27 | 2025 | Navicross, Angio-Seal, Glidesheath Slender |
| Bard Peripheral Vascular, INC. | $14.44 | 2022 | |
| Bolder Surgical LLC | $14.22 | 2019 | |
| Boston Scientific Corporation | $13.48 | 2024 | Varithena Administration Pack |
| Kerecis Limited | $13.48 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Avinger INC. | $11.78 | 2020 | |
| Sirtex Medical INC | $9.50 | 2024 | Lava Les (Liquid Embolic System) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Tapper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.